產品詳情
簡單介紹：
Anti-HSPABP/HIP/HSC70 Interacting Protein HIP抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-HSPABP/HIP/HSC70 Interacting Protein HIP抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-HSPABP/HIP/HSC70 Interacting Protein HIP
Cat. Number:
Anti-HSPABP/HIP/HSC70 Interacting Protein HIP抗體KL-11271R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Hip (HSP70-interacting protein), also known as ST13 (suppression of tumorigenicity protein 13), is one of several co-chaperones thatAnti-HSPABP/HIP/HSC70 Interacting Protein HIP抗體 regulate activities of the HSP70 chaperone family (1,2). The homo-oligomeric protein Hip cooperates with HSP70 in protein folding by stabilizing the ADP-bound state of HSP70. Hip directly binds to the ATPase domain of HSP70 when it is converted to the ADP-bound state by proteins of the HSP40 family (3). By collaborating with other positive co-factors such as HSP40 and Hop, or competing with negative co-factors such as Bag1, Hip may facilitate the chaperone function of HSP70 in protein folding and repair, and in controlling the activity of regulatory proteins such as steroid receptors and various regulators of proliferation or apoptosis (4-8).
Also known as:
AAG 2; AAG2; Aging associated protein 2; Anti-HSPABP/HIP/HSC70 Interacting Protein HIP抗體F10A1_HUMAN; FAM10A1; FAM10A4; FLJ27260; Heat shock 70kD protein binding protein; HIP; HOP; Hsc70 interacting protein; Hsc70-interacting protein; Hsp70 interacting protein; HSPABP 1; HSPABP; HSPABP1; MGC129952; OTTHUMP00000028873; P48 antibody PRO0786; Progesterone receptor associated p48 protein; Progesterone receptor-associated p48 protein; Protein FAM10A1; Putative tumor suppressor ST13; Renal carcinoma antigen NY REN 33; Renal carcinoma antigen NY-REN-33; SNC 6; SNC6; ST 13; ST13; Suppression of tumorigenicity 13; Suppression of tumorigenicity 13 (c
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .Anti-HSPABP/HIP/HSC70 Interacting Protein HIP抗體
●
Immunogen: KLH conjugated synthetic peptide derived from human HSPABP.
●
Predicted Molecular Weight: 41kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-HSPABP/HIP/HSC70 Interacting Protein HIP抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-HSPABP/HIP/HSC70 Interacting Protein HIP抗體
Optimal working dilutions must be determined by the end user.
kl166Ra01 胃蛋白酶原C(PGC)多克隆抗體 Polyclonal Antibody to Pepsinogen C (PGC)
kl167Hu01 前列腺素E合酶(PTGES)多克隆抗體 Polyclonal Antibody to Prostaglandin E Synthase, Microsomal (PTGES)
kl168Hu01 前列腺酸性磷酸酶(ACP3)多克隆抗體 Polyclonal Antibody to Acid Phosphatase 3, Prostatic (ACP3)
kl171Hu01 安眠蛋白1α(MEP1α)多克隆抗體 Polyclonal Antibody to Meprin A Alpha (MEP1a)
kl172Bo01 血小板因子4(PF4)多克隆抗體 Polyclonal Antibody to Platelet Factor 4 (PF4)
kl172Cp01 血小板因子4(PF4)多克隆抗體 Polyclonal Antibody to Platelet Factor 4 (PF4)
kl172Hu01 血小板因子4(PF4)多克隆抗體 Polyclonal Antibody to Platelet Factor 4 (PF4)
kl172Mu01 血小板因子4(PF4)多克隆抗體 Polyclonal Antibody to Platelet Factor 4 (PF4)
kl172Po01 血小板因子4(PF4)多克隆抗體 Polyclonal Antibody to Platelet Factor 4 (PF4)
kl172Ra01 血小板因子4(PF4)多克隆抗體 Polyclonal Antibody to Platelet Factor 4 (PF4)
kl172Rb51 血小板因子4(PF4)多克隆抗體 Polyclonal Antibody to Platelet Factor 4 (PF4)
kl174Hu01 髓鞘型脂肪酸結合蛋白(FABP8)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 8, Myelin (FABP8)
kl175Hu01 干擾素α4(IFNα4)多克隆抗體 Polyclonal Antibody to Interferon Alpha 4 (IFNa4)
kl177Hu01 酸性葡糖苷酶α(GαA)多克隆抗體 Polyclonal Antibody to Glucosidase Alpha, Acid (GaA)
kl179Hu01 干擾素α2(IFNα2)多克隆抗體 Polyclonal Antibody to Interferon Alpha 2 (IFNa2)
kl181Ca01 中性粒細胞彈性蛋白酶(ELA2)多克隆抗體 Polyclonal Antibody to Elastase 2, Neutrophil (ELA2)
kl181Hu01 中性粒細胞彈性蛋白酶(ELA2)多克隆抗體 Polyclonal Antibody to Elastase 2, Neutrophil (ELA2)
